CRISPR Journal
Scope & Guideline
Advancing the Future of Gene Editing
Introduction
Aims and Scopes
- Genome Editing Techniques and Innovations:
The journal extensively covers novel advancements in CRISPR-based genome editing techniques, including Cas9, Cas12, and base editing, focusing on their mechanisms, efficiency, and applications in various organisms. - Clinical Applications and Therapeutics:
Research on the translation of CRISPR technologies into clinical settings is a significant focus area, including studies on gene therapies for genetic disorders, cancer treatment, and potential applications in regenerative medicine. - Ethics and Policy in Genome Editing:
The journal addresses the ethical implications and regulatory considerations surrounding CRISPR technologies, particularly in the context of human germline editing and the societal impacts of genome editing. - Synthetic Biology and CRISPR Integration:
There is a growing emphasis on the integration of CRISPR with synthetic biology, exploring how these technologies can be used to engineer biological systems for various applications, including agriculture and environmental science. - Off-Target Effects and Safety Assessments:
The journal highlights research addressing the safety and precision of CRISPR editing, including studies on off-target effects, evaluation methodologies, and improvements in targeting accuracy.
Trending and Emerging
- Prime Editing and Next-Generation Editing Technologies:
Prime editing has gained significant attention as a next-generation genome-editing technique, with recent publications exploring its potential advantages over traditional CRISPR methods, including increased precision and reduced off-target effects. - CRISPR in Clinical Trials and Therapeutics:
There is a marked increase in research related to the transition of CRISPR technologies into clinical trials, emphasizing the therapeutic potential of genome editing for treating genetic disorders and cancers. - Artificial Intelligence in CRISPR Research:
The intersection of AI and CRISPR technology is emerging as a vital theme, with papers focusing on how machine learning can enhance CRISPR design, predict outcomes, and optimize editing strategies. - Ethical Considerations of Gene Editing:
With the rapid advancements in CRISPR technology, discussions around the ethical implications of genome editing, particularly in human applications, have become increasingly prominent in the journal. - CRISPR Applications Beyond Gene Editing:
Research exploring CRISPR applications in diagnostics, biosensing, and synthetic biology is on the rise, indicating a shift towards broader uses of CRISPR technologies beyond traditional gene editing.
Declining or Waning
- Basic Mechanistic Studies of CRISPR Systems:
There has been a noticeable decline in publications focusing solely on the basic biological mechanisms of CRISPR systems, as the field shifts towards applied research and clinical applications. - Agricultural Applications of CRISPR:
Although still relevant, the frequency of studies specifically targeting agricultural improvements through CRISPR has diminished, likely due to a growing emphasis on human health applications and clinical research. - Historical and Philosophical Perspectives on CRISPR:
Papers discussing the historical development and philosophical implications of CRISPR technologies have become less common as the journal prioritizes empirical research and immediate applications. - Single-Organism Studies:
Research focusing exclusively on CRISPR applications in single organisms, particularly non-model organisms, has decreased as the community increasingly values studies with broader implications across multiple species. - Regulatory Frameworks for Non-Human Editing:
The focus on regulatory considerations for non-human CRISPR applications, such as in environmental or agricultural contexts, has waned, possibly overshadowed by the urgency of human health applications.
Similar Journals
MedComm
Unleashing Potential in Drug Discovery and GeneticsMedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.
GENOME BIOLOGY
Fostering innovation in genome research and knowledge exchange.GENOME BIOLOGY is a premier, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genomics, molecular biology, and bioinformatics. Accessible as an Open Access journal since 2000, it aims to disseminate high-quality, cutting-edge research that contributes to our understanding of genome biology's intricate mechanisms. The journal boasts an impressive impact, ranking 8th in Agricultural and Biological Sciences and 9th in Biochemistry, Genetics and Molecular Biology, highlighting its significance among scholars, professionals, and students alike. With a commitment to facilitating the exchange of invaluable scientific knowledge, GENOME BIOLOGY provides an important platform for discussions on evolutionary biology, genetic systems, and cell biology, contributing to the advancement of these dynamic disciplines.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Pioneering research for a healthier tomorrow.International Journal of Molecular Medicine is a prestigious publication dedicated to advancing the field of molecular medicine through innovative research and scholarly dialogue. Published by Spandidos Publications Ltd in Greece, this journal has successfully provided a platform for academics and professionals alike since its inception in 1998. With an impressive 2023 Q1 ranking in Medicine (Miscellaneous) and a Q2 ranking in Genetics, the journal maintains a vital role in disseminating high-quality research, underscored by its strong performance in the Scopus rankings, particularly in the realm of genetics where it ranks 28 out of 347. Researchers will benefit from its comprehensive scope, which encompasses a wide range of topics within molecular biology, genetics, and their clinical applications. Although the journal does not operate under an open access model, it remains influential, providing critical insights that contribute significantly to the understanding and development of molecular therapeutic strategies and innovations.
Plant Biotechnology
Pioneering Discoveries in Plant Biotechnology.Plant Biotechnology is a distinguished journal published by the Japanese Society for Plant Cell and Molecular Biology, committed to advancing the field of plant biotechnology through the dissemination of high-quality research. With an ISSN of 1342-4580, this journal caters to a global audience interested in agronomy, crop science, and plant molecular biology. The journal has achieved notable rankings, including Q2 in Agronomy and Crop Science and Q2 in Plant Science, underscoring its relevance and impact in these fields according to the latest 2023 metrics. Furthermore, it holds a respectable position within Scopus rankings across multiple categories, indicating its contribution to the academic community. Although it is not an open-access journal, its regular publications, spanning from 1997 to 2024, feature cutting-edge studies that explore innovative approaches and technologies in plant science. Researchers, professionals, and students will find Plant Biotechnology an essential resource for staying informed on significant advancements and trends in plant research.
GENETICS AND MOLECULAR BIOLOGY
Exploring the DNA of innovation in research.GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.
EXPERIMENTAL ANIMALS
Pioneering research that shapes the future of biochemistry and genetics.EXPERIMENTAL ANIMALS is a leading journal that serves the vibrant fields of Animal Science, Veterinary Medicine, and Biochemistry, Genetics, and Molecular Biology, published by the prestigious INT PRESS EDITING CENTRE INC in Japan. Boasting an impressive track record since its inception in 1974, the journal has positioned itself as a crucial platform for researchers aiming to disseminate innovative findings in experimental animal research. With a commendable impact factor and categorized in the Q2 and Q3 quartiles by Scopus in various relevant fields for 2023, EXPERIMENTAL ANIMALS exemplifies excellence in its contributions to science. The journal offers a comprehensive range of articles spanning from animal welfare and experimental methodologies to genetic studies, ensuring a multidisciplinary approach that appeals to a diverse audience of researchers, professionals, and students. Access to its wealth of knowledge fosters significant advancements in research and practice, underlining the journal's commitment to enhancing understanding of animal models in scientific inquiry.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Fostering Collaboration in the World of Molecular DiscoveriesCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.
Molecular Therapy Methods & Clinical Development
Empowering collaboration in gene and cell therapy.Molecular Therapy Methods & Clinical Development, published by CELL PRESS, is a premier Open Access journal dedicated to advancing the field of gene and cell therapy through innovative methodologies and clinical developments. Since its inception in 2014, the journal has garnered significant attention within the research community, achieving impressive Q1 quartile rankings in Genetics, Molecular Biology, and Molecular Medicine as of 2023. With a commendable Scopus ranking that positions it within the top echelons of its categories, this journal serves as an essential platform for researchers, professionals, and students alike, providing access to cutting-edge research that drives the future of therapeutic approaches. With its commitment to Open Access, readers worldwide can easily access high-quality and impactful content that fosters collaboration and knowledge-sharing in this rapidly evolving domain. The journal’s scope encompasses crucial advancements in therapeutic methodologies, ensuring that it remains at the forefront of scientific discourse and innovation.
BMB Reports
Connecting Minds, Transforming MedicineBMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
Advancing Innovations in Biochemistry and BiotechnologyApplied Biochemistry and Biotechnology is a leading journal published by Springer, dedicated to advancing research in the interdisciplinary fields of biochemistry, biotechnology, and applied microbiology. Established in 1981, this peer-reviewed journal covers a wide range of topics that encompass innovative techniques, methodologies, and applications of biochemistry and biotechnology in medicine, environmental engineering, and molecular biology. With a Q2 ranking in several categories and an increasing impact factor, the journal demonstrates significant influence and credibility within the scientific community. While traditionally subscription-based, the journal offers avenues for open access through selective agreements, making high-quality research accessible to a broader audience. Researchers, professionals, and students alike will find Applied Biochemistry and Biotechnology to be an invaluable resource for the latest developments and applications in biochemistry and its related fields, aiding in the quest for sustainable solutions and novel biotechnological advancements.